Literature DB >> 12693661

Activation of macrophage-associated molecules after brain death in islets.

Hirochika Toyama1, Moriatsu Takada, Yasuyuki Suzuki, Yoshikazu Kuroda.   

Abstract

Islet transplantation is now established as an optional treatment for type I diabetes. However, rates of insulin independence in islet transplant recipients are still low. Although the major source of allograft is derived from brain-dead patient, the nonphysiologic state of brain death (BD) deteriorates organs such as liver and kidney. To determine the effects of BD on islets, a rodent model of BD has been used. Histologically, islets of BD rats showed decreased permeability and impaired integrity of the cell membranes. Flow cytometric analysis showed that CD11b/c-positive cells within islets were slightly increased in BD. This result suggests that BD induces macrophage infiltration into the islets. Moreover, RT-PCR revealed significant augmentation of macrophages-associated inflammatory molecules (IL-1beta, IL-6, TNF-alpha, and MCP-1) in islets from a BD donor. Inducible nitric oxide synthase (iNOS) was weakly expressed, although not reaching statistical significance compared with control. Our results indicate that islets from a BD donor are immunologically activated and have a potential risk factor for early graft loss and a poor long-term function of grafts in clinical setting of islet transplantation. Immunomodulation, to eliminate intraislet immunocytes and/or activated macro phage-associated molecules, might be necessary for the better outcome after islet graft from BD donors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12693661     DOI: 10.3727/000000003783985205

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  13 in total

Review 1.  Ischaemia is linked to inflammation and induction of angiogenesis in pancreatic islets.

Authors:  T Linn; J Schmitz; I Hauck-Schmalenberger; Y Lai; R G Bretzel; H Brandhorst; D Brandhorst
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

Review 2.  Resolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation.

Authors:  Xiaolun Huang; Daniel J Moore; Robert J Ketchum; Craig S Nunemaker; Boris Kovatchev; Anthony L McCall; Kenneth L Brayman
Journal:  Endocr Rev       Date:  2008-07-29       Impact factor: 19.871

3.  Evidence of stress in β cells obtained with laser capture microdissection from pancreases of brain dead donors.

Authors:  Aref Ebrahimi; Min-Ho Jung; Jonathan M Dreyfuss; Hui Pan; Dennis Sgroi; Susan Bonner-Weir; Gordon C Weir
Journal:  Islets       Date:  2017-03-04       Impact factor: 2.694

Review 4.  Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes.

Authors:  Jun Panee
Journal:  Cytokine       Date:  2012-07-04       Impact factor: 3.861

5.  P38alpha-selective mitogen-activated protein kinase inhibitor for improvement of cultured human islet recovery.

Authors:  Keiko Omori; Ivan Todorov; Jonathan Shintaku; Jeffrey Rawson; Ismail H Al-Abdullah; Linda S Higgins; Satyanarayana Medicherla; Fouad Kandeel; Yoko Mullen
Journal:  Pancreas       Date:  2010-05       Impact factor: 3.327

6.  Beta-cell replication is increased in donor organs from young patients after prolonged life support.

Authors:  Peter In't Veld; Neelke De Munck; Kristien Van Belle; Nicole Buelens; Zhidong Ling; Ilse Weets; Patrick Haentjens; Miriam Pipeleers-Marichal; Frans Gorus; Daniel Pipeleers
Journal:  Diabetes       Date:  2010-04-22       Impact factor: 9.461

7.  Inhibition of c-jun N terminal kinase (JNK) improves functional beta cell mass in human islets and leads to AKT and glycogen synthase kinase-3 (GSK-3) phosphorylation.

Authors:  A Fornoni; A Pileggi; R D Molano; N Y Sanabria; T Tejada; J Gonzalez-Quintana; H Ichii; L Inverardi; C Ricordi; R L Pastori
Journal:  Diabetologia       Date:  2007-12-08       Impact factor: 10.122

8.  Toll-like receptor 4 (TLR4) expression in human and murine pancreatic beta-cells affects cell viability and insulin homeostasis.

Authors:  Humberto M Garay-Malpartida; Roberta F Mourão; Marluce Mantovani; Icaro A Santos; Mari C Sogayar; Anna C Goldberg
Journal:  BMC Immunol       Date:  2011-02-28       Impact factor: 3.615

9.  Systems biology of the IMIDIA biobank from organ donors and pancreatectomised patients defines a novel transcriptomic signature of islets from individuals with type 2 diabetes.

Authors:  Michele Solimena; Anke M Schulte; Lorella Marselli; Florian Ehehalt; Daniela Richter; Manuela Kleeberg; Hassan Mziaut; Klaus-Peter Knoch; Julia Parnis; Marco Bugliani; Afshan Siddiq; Anne Jörns; Frédéric Burdet; Robin Liechti; Mara Suleiman; Daniel Margerie; Farooq Syed; Marius Distler; Robert Grützmann; Enrico Petretto; Aida Moreno-Moral; Carolin Wegbrod; Anke Sönmez; Katja Pfriem; Anne Friedrich; Jörn Meinel; Claes B Wollheim; Gustavo B Baretton; Raphael Scharfmann; Everson Nogoceke; Ezio Bonifacio; Dorothée Sturm; Birgit Meyer-Puttlitz; Ugo Boggi; Hans-Detlev Saeger; Franco Filipponi; Mathias Lesche; Paolo Meda; Andreas Dahl; Leonore Wigger; Ioannis Xenarios; Mario Falchi; Bernard Thorens; Jürgen Weitz; Krister Bokvist; Sigurd Lenzen; Guy A Rutter; Philippe Froguel; Manon von Bülow; Mark Ibberson; Piero Marchetti
Journal:  Diabetologia       Date:  2017-11-28       Impact factor: 10.122

10.  Multi-omics profiling of living human pancreatic islet donors reveals heterogeneous beta cell trajectories towards type 2 diabetes.

Authors:  Leonore Wigger; Marko Barovic; Andreas-David Brunner; Flavia Marzetta; Eyke Schöniger; Florence Mehl; Nicole Kipke; Daniela Friedland; Frederic Burdet; Camille Kessler; Mathias Lesche; Bernard Thorens; Ezio Bonifacio; Cristina Legido-Quigley; Pierre Barbier Saint Hilaire; Philippe Delerive; Andreas Dahl; Christian Klose; Mathias J Gerl; Kai Simons; Daniela Aust; Jürgen Weitz; Marius Distler; Anke M Schulte; Matthias Mann; Mark Ibberson; Michele Solimena
Journal:  Nat Metab       Date:  2021-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.